| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0019400 | Intron-Intron | chr10:31773377-31775371 | chr10:31484448-31486442 | 1995 nt | 0.3293 |
| hsa_ZEB1_0019500 | Intron-Intron | chr10:31774421-31775141 | chr10:31485492-31486212 | 721 nt | 0.3218 |
| hsa_ZEB1_0019600 | Intron-Exon-Intron | chr10:31780628-31791437 | chr10:31491699-31502509 | 78 nt | 0.3333 |
| hsa_ZEB1_0019700 | Intron-Exon-Intron | chr10:31780628-31799803 | chr10:31491699-31510875 | 203 nt | 0.3793 |
| hsa_ZEB1_0019800 | Intron-Exon-Intron | chr10:31780628-31803636 | chr10:31491699-31514708 | 106 nt | 0.3868 |
| hsa_ZEB1_0020200 | Exon-Exon | chr10:31784705-31791437 | chr10:31495776-31502509 | 225 nt | 0.4667 |
| hsa_ZEB1_0020300 | Exon-Exon | chr10:31784705-31803636 | chr10:31495776-31514708 | 434 nt | 0.4263 |
| hsa_ZEB1_0020000 | Exon-Exon | chr10:31784705-31816045 | chr10:31495776-31527117 | 2972 nt | 0.4303 |
| hsa_ZEB1_0020100 | Exon-Exon | chr10:31784705-31817068 | chr10:31495776-31528140 | 250 nt | 0.3400 |
| hsa_ZEB1_0020500 | Exon-Exon | chr10:31784708-31791437 | chr10:31495779-31502509 | 162 nt | 0.4383 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].